Workflow
Tumor - Infiltrating Lymphocyte (TIL) therapy
icon
Search documents
Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts
Yahoo Financeยท 2025-09-20 06:43
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best healthcare penny stocks to buy now. On September 9, at the H.C. Wainwright 27th Annual Global Investment Conference, the company reiterated its growth and cost-cutting initiatives. Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts Photographee.eu/Shutterstock.com Part of the plan involves the commercial expansion of Amtagvi (lifileucel) for advanced melanoma, as the company seeks to strengthen its revenue bas ...